2Wang L,Harris TE,Roth RA,et al.PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding[J].J Biol Chem,2007,282(27):20036-20044.
3Ma L,Chen Z,Erdjument-Bromage H,et al.Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis[J].Cell,2005,121(2):179-193.
4DeYoung MP,Horak P,Sofer A,et al.Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling[J].Genes Dev,2008,22(2):239-251.
5Porstmann T,Santos CR,Griffiths B,et al.SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth[J].Cell Metab,2008,8(3):224-236.
6Delgoffe GM, Powell JD. roTOR: taking cues from the immune microenvironment[J]. Immunology, 2009, 127(4): 459-465.
7Chi H. Regulation and function of mTOR signalling in T cell fate decisions[J]. Nat Rev Immunol, 2012, 12(5): 325-338.
8Powell JD, Pollizzi KN, Heikamp EB, et al. Regulation of immune responses by mTOR[J]. Annu Rev Immunol, 2012, 30: 39-68.
9Limon JJ, Fruman DA. Akt and roTOR in B cell activation and differentiation[J]. Front Immunol, 2012, 3: 228.
10Zhang S, Pruitt M, Tran D, et al. B cell-specific deficiencies in mTOR limit humoral immune responses[J]. J Immunol, 2013, 191(4): 1962-1703.
